The Q4 numbers are in for fledgling broad-line semiconductor maven Marvell Technology
Management currently doesn't think it will be able to file its 10-K report by the Mar. 28 deadline, though it did say that the review is nearing its end, and that we should expect some more information in the near future.
Marvell is far from the only company affected by these stock option troubles, and it isn't even the highest-profile miscreant. Apple
But back to what we do know about Marvell. The quarter included between $90 million and $100 million of revenues from the recently acquired XScale product line, a former Intel
Marvell does have a few growth opportunities on its plate, though. The company is starting to look like a smaller clone of Texas Instruments
Another bright spot is 802.11n wireless networking, as demand has started to catch up with the enthusiastically scaled production of these early-draft networking chips. That should be good news for other networking players like Intel, Broadcom, and Atheros
It would have been nice to see estimated earnings, operating cash flow, or maybe just EBITDA numbers, but no such luck. Keep up the good work, gentlemen, and let us know when you can give us a clearer picture. Of your financials, not on my TV.
- Marvell's Results On Hold
- Intel's Marvell-ous Venture
- Too Marvell-ous to Be True
- 3 Ways to Better Growth Stocks
Atheros is a Motley Fool Hidden Gems recommendation. Home Depot, UnitedHealth, and Intel are Motley Fool Inside Value selections. UnitedHealth has also been recommended by Stock Advisor. Pick up a couple of free 30-day trial subscriptions to get the story, the whole story, and nothing but the story.